MARKET

BNTX

BNTX

BIONTECH
NASDAQ
86.50
+1.00
+1.17%
After Hours: 86.50 0 0.00% 16:15 06/09 EDT
OPEN
86.64
PREV CLOSE
85.50
HIGH
87.05
LOW
84.96
VOLUME
1.17M
TURNOVER
--
52 WEEK HIGH
124.00
52 WEEK LOW
79.52
MARKET CAP
21.87B
P/E (TTM)
-14.7858
1D
5D
1M
3M
1Y
5Y
1D
BioNTech Launches $1 Billion ADS Share Buyback Program on Nasdaq
TipRanks · 1d ago
Weekly Report: what happened at BNTX last week (0601-0605)?
Weekly Report · 1d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)
TipRanks · 4d ago
Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian
Seeking Alpha · 5d ago
Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Bold $499 Fair Value Narrative
Simply Wall St · 5d ago
Bernstein Sticks to Their Hold Rating for BioNTech SE (BNTX)
TipRanks · 06/02 13:01
How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO
Simply Wall St · 06/02 10:36
BioNTech and Bristol Myers Squibb Report Strong Interim Phase 2 Lung Cancer Data for Bispecific Pumitamig
TipRanks · 06/01 12:33
More
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Webull offers BioNTech SE - ADR stock information, including NASDAQ: BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.